share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Stewart Jeffrey Ryan

SEC announcement ·  Mar 20 17:03
Summary by Moomoo AI
Jeffrey Ryan Stewart, EVP and Chief Commercial Officer of AbbVie Inc., completed a series of transactions on March 18, 2024, involving the company's common stock. Stewart exercised options to acquire 26,110 shares at a price of $61.36 per share. Subsequently, he sold a total of 58,949 shares through open market transactions at prices ranging from $178.69 to $179.03, resulting in a total market value of $10,539,508.07. After these transactions, Stewart's direct holdings in AbbVie common stock amounted to 60,941 shares. Additionally, it was reported that 1,338 shares are held indirectly by Stewart's spouse in trust.
Jeffrey Ryan Stewart, EVP and Chief Commercial Officer of AbbVie Inc., completed a series of transactions on March 18, 2024, involving the company's common stock. Stewart exercised options to acquire 26,110 shares at a price of $61.36 per share. Subsequently, he sold a total of 58,949 shares through open market transactions at prices ranging from $178.69 to $179.03, resulting in a total market value of $10,539,508.07. After these transactions, Stewart's direct holdings in AbbVie common stock amounted to 60,941 shares. Additionally, it was reported that 1,338 shares are held indirectly by Stewart's spouse in trust.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more